Intas to buy Actavis UK and Ireland business form Teva
Indian drugmaker Intas Pharmaceuticals has agreed to acquire Actavis Generics’ assets and operations in the UK and Ireland from Teva Pharmaceutical Industries for about £603m.
Click on this link for more information.
